Up-regulation of circRIP2 encourages bladder cancer via Tgf-β2 induced EMT; inhibiting Tgf-β2 significantly deprives circRIP2 mediated bladder cancer progression. Here, TGFB2 is linked to urinary bladder carcinoma.